Patient reported outcomes in head and neck cancer: selecting instruments for quality of life integration in clinical protocols
Health Related Quality of Life has been used in medical research for more than twenty years, being progressively accepted during the last decade as an important patient reported outcome. Considering the multidimensional approach involved in Health Related Quality of Life assessment, instrument applicability and cultural adaptation must be tested for each population. In order to select the most appropriate instrument for Head and Neck cancer patients, two major Health Related Quality of Life specific questionnaires for Head and Neck cancer patients were compared. Conceptual differences, psychometric characteristics, scores, reliability, construct validity and sensitivity to symptomatology, tumour location, tumour size were analyzed.
102 consecutive Head and Neck cancer patients completed two different Health Related Quality of Life questionnaires: EORTC QLQ-C30 and its specific head and neck module QLQ-H&N35 and the Functional Assessment of Cancer Therapy Scales (FACT-H&N). Patients completed the questionnaires, immediately before consultation as a part of the routine evaluation.
A greater variability was always found in the EORTC QLC-C30 questionnaire's scores for all comparable domains. Both instruments revealed a good internal consistency and demonstrated to be good tools to distinguish symptomatic patients. The EORTC questionnaires still demonstrated sensitivity to distinguish T3 and T4 staging. Conceptual differences and the psychometric characteristics are discussed. Our results suggest that these two instruments assess different aspects of Health Related Quality of Life - the questionnaires should be used separately and chosen according to the study objectives and methodology.
This study emphases the importance in selecting the appropriate tool as a critical success factor in implementing routine Health Related Quality of Life assessment in clinical practice. This decision assumes particularly importance when utilization of results in real time and integration into clinical protocols are considered.
- Torres-Carranza E, Infante-Cossío P, Hernández-Guisado JM, Hens-Aumente E, Gutierrez-Pérez JL: Assessment of quality of life in oral cancer. Med Oral Patol Oral Cir Bucal 2008, 13 (11) : E735–41.
- Kruse AL, Bredell M, Luebbers HT, Gratz KW: Head and Neck Cancer in the Elderly: A Retrospective Study over 10 Years (1999 - 2008). Head & Neck Oncology 2010, 2: 2. CrossRef
- Koller M, Lorenz W: Quality of life: a deconstruction for clinicians. J R Soc Med 2002, 95: 481–488. CrossRef
- Wierzbicka M, Kuśnierkiewicz M, Wójtowicz JG, Maune S, Szyfter W: The quality of life in head and neck cancer patients: description of randomized examination formula based on standardized questionnaires EORTC QLQ C-30, EORTC QTQ-H-N35 and Kiel Questionnaire. Otolaryngol Pol 2001, 55: 287–92.
- Rogers SN, Ahad SA, Murphy AP: A structured review and theme analysis of papers published on 'quality of life' in head and neck cancer: 2000–2005. Oral Oncol 2007, 43: 843–68. CrossRef
- Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran DA, Bottomley A: On behalf of the EORTC Quality o Life Group. EORTC QLQ-C30 Scoring Manual. In Guidelines for assessing Quality of Life in EORTC Clinical Trials. 3rd edition. Brussels, EORTC; 2001.
- Terrell JE, Ronis DL, Fowler KE, Bradford CR, Chepeha DB, Prince ME, Teknos TN, Wolf GT, Duffy SA: Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surgery 2004, 130: 401–408. CrossRef
- Karvonen-Gutierrez CA, Ronis DL, Fowler KE, Terrell JE, Gruber SB, Duffy SA: Quality of life scores predict survival among patients with head and neck cancer. J Clin Oncol 2008, 26: 2754–60. CrossRef
- Yeo W, Mo FK, Koh J, Chan AT, Leung T, Hui P, Chan L, Tang A, Lee JJ, Mok TS, Lai PB, Johnson PJ, Zee B: Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma. Ann Oncol 2006, 1083–1089.
- Luoma ML, Hakamies-Blomqvist L, Sjöström J, Pluzanska A, Ottoson S, Mouridsen H, Bengtsson NO, Bergh J, Malmström P, Valvere V, Tennvall L, Blomqvist C: Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer. Eur J Cancer 2003, 39: 1370–1376. CrossRef
- Mehanna HM, Morton RP: Patients' views on the utility of quality of life questionnaires in head and neck cancer: a randomised trial. Clin Otolaryngol 2006, 31: 310–316. CrossRef
- Meeuwsen EJ, German P, Melis RJ, Adang EM, Golüke-Willemse GA, Krabbe PF, de Leest BJ, van Raak FH, Schölzel-Dorenbos CJ, Visser MC, Wolfs CA, Vliek S, Rikkert MG: Cost-effectiveness of post-diagnosis treatment in dementia coordinated by Multidisciplinary Memory Clinics in comparison to treatment coordinated by general practitioners: an example of a pragmatic trial. J Nutr Health Aging 2009, 13: 242–248. CrossRef
- Kim MM, Califano JA: Molecular pathology of head-and-neck cancer. Int J Cancer 2004, 112: 545–553. CrossRef
- Hilarius DL, Gundy CM, Aaronson NK: Use of health-related quality-of-life assessments in daily clinical oncology nursing practice: a community hospital-based intervention study. Cancer 2008, 113: 628–37. CrossRef
- Chang JT, Juang YY, Hsiao JC, Lin CY, Huang SF, Huang YC, Kuan KH, Liao CT, Wang HM, Chen IH: Internal consistency of the traditional Chinese character version of the Functional Assessment of Cancer Therapy-Head and Neck (FACT-H&N). Chang Gung Med J 2008, 31: 384–394.
- Pimentel FL: Qualidade de Vida - revisão bibliográfica. Qualidade de Vida do Doente Oncológico, Edição: De autor 2003.
- Infante-Cossio P, Torres-Carranza E, Cayuela A, Hens-Aumente E, Pastor-Gaitan P, Gutierrez-Perez JL: Impact of treatment on quality of life for oral and oropharyngeal carcinoma. Int J Oral Maxillofac Surg 2009, 38: 1052–8. CrossRef
- Ringash J, O'Sullivan B, Bezjak A, Redelmeier DA: Interpreting clinically significant changes in patient-reported outcomes. Cancer 2007, 110: 196–202. CrossRef
- Cheung YB, Goh C, Thumboo J, Khoo K, Wee J: Quality of life scores differed according to mode of administration in a review of three major oncology questionnaires. Journal of Clinical Epidemiology 2006, 59: 185–191. CrossRef
- Holzner B, Bode RK, Hahn EA, Cella D, Kopp M, Sperner-Unterweger B, Kemmler G: Equating EORTC QLQ-C30 and FACT-G scores and its use in oncological research. Eur J Cancer 2006, 42: 3169–77. CrossRef
- Rogers SN, Ahad SA, Murphy AP: A structured review and theme analysis of papers published on 'quality of life' in head and neck cancer:2000–2005. Oral Oncology 2007, 43: 843–868. CrossRef
- Kemmler G, Holzner B, Kopp M, Dunser M, Margreiter R, Greil R, Sperner-Unterweger B: Comparison of two quality-of-life instruments for cancer patients: The Functional Assessment of Cancer Therapy. General and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 1999, 17: 2932–2940.
- Rogers SN, Lowe D, Brown JS, Vaughan ED: A comparision between the University of Washington head and neck disease-specific measure and the Medical Short form 36, EORTC QLQ-C33 and EORTC-H&N35. Oral Oncology 1998, 34: 361–372. CrossRef
- de Bree R, Verdonck-de Leeuw IM, Keizer AL, Houffelaar A, Leemans CR: Touch screen computer-assisted health-related quality of life and distress data collection in head and neck cancer patients. Clinical Otolaryngology 2008, 33: 138. CrossRef
- Sayed SI, Elmiyeh B, Rhys-Evans P, Syrigos KN, Nutting CM, Harrington KJ, Kazi R: Quality of life and outcomes research in head and neck cancer: A review of the state of the discipline and likely future directions. Cancer Treatment Reviews 2009, 35: 397–402. CrossRef
- Trask PC, Hsu MA, McQuellon R: Other paradigms: health-related quality of life as a measure in cancer treatment: its importance and relevance. Cancer 2009, 15: 435–40. CrossRef
- Coyne JC, Pajak TF, Harris J, Konski A, Movsas B, Ang K, Watkins Bruner D: Emotional well-being does not predict survival in head and neck cancer patients: a Radiation Therapy Oncology Group. Cancer 2008, 112: 2326–7. CrossRef
- Barnes ML, Williamson PA, Lipworth BJ: The minimal clinically important difference in allergic rhinitis. Clin Exp Allergy 2010, 40: 242–50. CrossRef
- Vaidyanathan S, Barnes M, Lipworth B: R159: Minimal Clinically Important Differences in Rhinology. Otolaryngolog -Head and Neck Surgery 2007, 137: 206. CrossRef
- Johnson S, Corsten MJ, McDonald JT, Chun J: Socio-economic factors and stage at presentation of head and neck cancer patients in Ottawa, Canada: A logistic regression analysis. Oral Oncology 2010, 46: 366–368. CrossRef
- Pinheiro PS, Tyczynski JE, Bray F, Amado J, Matos E, Miranda AC, Limbert E: Cancer in Portugal/Cancro em Portugal. IARC Technical Publication 2002, 38.
- Cripps C, Winquist E, Devries MC, Stys-Norman D, Gilbert R: Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer. Curr Oncol 2010, 17: 37–48. CrossRef
- Scarpa R: Surgical Management of Head and Neck Carcinoma. Seminars in Oncology Nursing 2009, 25: 172–182. CrossRef
- Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A: Cancer statistics, 2005, CA. Cancer J Clin 2005, 55: 10–30. CrossRef
- Varricchio CG, Ferran CE: Quality of Life Assessments in Clinical Practice. Seminars in Oncology Nursing 2010, 26: 12–17. CrossRef
- Janse AJ, Gemke BJ, Uiterwaal PM, van der Tweel I, Kimpen LL, Sinnema G: Quality of life: patients and doctors don't always agree: a meta-analysis. Journal of Clinical Epidemiology 2004, 57: 653–661. CrossRef
- Conroy T, Mercier M, Bonneterre J, Luporsi E, Lefevre JL, Lapeyre M, Puyraveau M, Schraub S: French version of FACT-G: Validation and comparison with other cancer-specific instruments. European Journal of Cancer 2004, 40: 2243–2252. CrossRef
- Bjordal K, de Graeff A, Fayers PM, Hammerlid van Posttelsberhge C, Curran D, Ahlner-Elmqvist M, Maher EJ, Meyza JW, Bredart A, Soderholm AL, Arraras JJ, Feine JS, Abendstein H, Morton RP, Pignon T, Huguenin P, Bottomly A, Kaasa S: A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer 2000, 36: 1796–1807. CrossRef
- Smith DJ, Huntington J, Sloan JA: Choosing the "Correct" Assessment Tool. Current Problems in Cancer 2006, 30: 272–282. CrossRef
- Holzner B, Kemmler G, Sperner-Unterweger B, Kopp M, Dunser M, Margreiter R, Marschitz I, Nachbaur D, Fleischhacker WW, Greil R: Quality of life measurement in concology-a matter of the assessment instrument? European Journal of Cancer 2001, 37: 2349–2356. CrossRef
- Patient reported outcomes in head and neck cancer: selecting instruments for quality of life integration in clinical protocols
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Head & Neck Oncology
- Online Date
- October 2010
- Online ISSN
- BioMed Central
- Additional Links
- Author Affiliations
- 1. Oral Anatomy and Oral Histology- Health Sciences Department, Fernando Pessoa University, Rua Carlos da Maia, 296, 4200-150, Porto, Portugal
- 2. Institute for Biomedical Sciences Abel Salazar, Porto University, Lg. Prof. Abel Salazar no. 2, 4099-003, Porto, Portugal
- 3. The Centre of Health Studies and Research of the Coimbra University, Av. Dias da Silva, 165, 3004-512, Coimbra, Portugal
- 4. Math Department, Polytechnic Institute of Cávado and Ave, Campus do IPCA - Lugar do Aldão, Vila Frescainha S. Martinho, 4750-810, Barcelos, Portugal
- 5. Institute for Molecular and Cell Biology, Rua do Campo Alegre, 823, 4150-180, Porto, Portugal
- 6. Health Sciences Department, Portuguese Catholic University, Campus Viseu Estrada da Circunvalação, 3504-505, Viseu, Portugal
- 7. Facultad De Medicina Y Odontologia Rua San Francisco, S/N, Santiago de Compostela University, 15704, Santiago De Compostela, Espanha
- 8. Health Sciences Department, Institute for Biomedical Sciences Abel Salazar- Porto University, Lg. Prof. Abel Salazar no. 2, 4099-003, Porto, Portugal
- 10. Portuguese Institute for Oncology - Porto, Otorhinolaringology service (IPO-Porto, ORL). Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal
- 9. Fernando Pessoa University, Rua Carlos da Maia, 296, 4200-150, Porto, Portugal
- 11. Aveiro University, Secção Autónoma Ciências da Saúde; Campus Universitário de Santiago, Aveiro, Portugal Infante D. Pedro Hospital, Aveiro, Av. Artur Ravara, 3814-501, Aveiro, Portugal